Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):441-3. doi: 10.1007/s00259-006-0264-6.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Artifacts*
  • Fluorodeoxyglucose F18* / administration & dosage
  • Fluorodeoxyglucose F18* / pharmacokinetics
  • Humans
  • Inflammation / diagnostic imaging*
  • Inflammation / etiology*
  • Neoplasms / diagnostic imaging*
  • Neoplasms / metabolism
  • Neoplasms / therapy
  • Osteoblasts / diagnostic imaging
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Osteoblasts / radiation effects
  • Positron-Emission Tomography / methods
  • Practice Guidelines as Topic
  • Prognosis
  • Radiopharmaceuticals / administration & dosage
  • Radiopharmaceuticals / pharmacokinetics
  • Radiotherapy / adverse effects*
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18